Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Health Catalyst ( (HCAT) ) has issued an announcement.
On July 9, 2025, Health Catalyst, Inc. held its annual meeting of stockholders, where four proposals were voted on. The stockholders elected two Class III directors, ratified the appointment of Ernst & Young LLP as the independent auditor, approved executive compensation, and supported a proposal to declassify the board of directors. These decisions reflect ongoing governance and operational strategies aimed at enhancing the company’s leadership structure and financial oversight.
The most recent analyst rating on (HCAT) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Health Catalyst stock, see the HCAT Stock Forecast page.
Spark’s Take on HCAT Stock
According to Spark, TipRanks’ AI Analyst, HCAT is a Neutral.
The overall stock score reflects a balance of strong revenue growth and positive earnings call outlook against profitability and cash flow challenges. Technical indicators suggest neutral momentum, while valuation remains a concern due to negative earnings.
To see Spark’s full report on HCAT stock, click here.
More about Health Catalyst
Health Catalyst, Inc. operates in the healthcare industry, primarily providing data and analytics technology and services to healthcare organizations. The company focuses on helping healthcare providers improve clinical, financial, and operational outcomes through its comprehensive suite of solutions.
Average Trading Volume: 572,257
Technical Sentiment Signal: Sell
Current Market Cap: $281.2M
See more data about HCAT stock on TipRanks’ Stock Analysis page.